All In Biotech

Drug Trial Radar · NCT07106021

A Study to Assess Safety and Efficacy of Surgical Implant of RNDP-001 in Patients With Idiopathic Parkinson's Disease

A Phase 1b/2a Study Assessing the Safety and Efficacy of Intraputamenal Dopaminergic Stem Cell Transplants in Patients With Idiopathic Parkinson's Disease

Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

12

Planned (sponsor's estimate)

Start

Jul 17, 2025

Primary completion

Sep 2027

Study completion Jun 2031

Sponsor

Lead sponsor
Kenai TherapeuticsIndustry
Sponsor type
Industry
Collaborators
California Institute for Regenerative Medicine (CIRM)
First posted
Aug 6, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 45 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This clinical trial is designed to test the safety and tolerability of the study intervention, RNDP-001, which will be implanted into the brain of study participants during a surgical procedure.

Conditions

  • Idiopathic Parkinson´s Disease
  • Parkinson's Disease

Interventions

  • RNDP-001Biological

    Stem cells

  • Syringe Front-Loading DeviceDevice

    Delivers the stem cells

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and TolerabilityTime frame: Baseline to 15 months post-transplant

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • University of Arizona

    Tucson, Arizona

  • Keck Medical Center of University of Southern California

    Los Angeles, California

  • The Ohio State University Wexner Medical Center

    Columbus, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.